Kenneth M. Merz
Corporate Officer/Principal at University of Florida
Profile
Kenneth M.
Merz currently works at the University of Florida, as Professor.
Dr. Merz also formerly worked at Pharmacopeia LLC, as Senior Director-ADMET, QuantumBio, Inc., as Director & Chief Scientific Officer, and The Pennsylvania State University, as Assistant, Associate & Chemistry Professor from 1989 to 2005.
Dr. Merz received his doctorate degree from The University of Texas at Austin and undergraduate degree from Washington College.
Kenneth M. Merz active positions
Companies | Position | Start |
---|---|---|
University of Florida | Corporate Officer/Principal | 15/02/2011 |
Former positions of Kenneth M. Merz
Companies | Position | End |
---|---|---|
The Pennsylvania State University | Corporate Officer/Principal | 01/01/2005 |
Pharmacopeia LLC
Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Corporate Officer/Principal | - |
QuantumBio, Inc.
QuantumBio, Inc. Miscellaneous Commercial ServicesCommercial Services QuantumBio, Inc. engages in the provision of software solutions. Its products include divcon command line, QMScore, NMRScore, XModelScore, and software licensing. The company was founded in 2002 and is headquartered in State College, PA. | Chief Tech/Sci/R&D Officer | - |
Training of Kenneth M. Merz
The University of Texas at Austin | Doctorate Degree |
Washington College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Pharmacopeia LLC
Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Health Technology |
QuantumBio, Inc.
QuantumBio, Inc. Miscellaneous Commercial ServicesCommercial Services QuantumBio, Inc. engages in the provision of software solutions. Its products include divcon command line, QMScore, NMRScore, XModelScore, and software licensing. The company was founded in 2002 and is headquartered in State College, PA. | Commercial Services |
- Stock Market
- Insiders
- Kenneth M. Merz